(IN BRIEF) QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its European Patent EP 2 276 883 B2, which covers innovations in QuantiFERON-TB Gold Plus used for TB detection. … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Law, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged bioMérieux, CDC, Düsseldorf, European Patent EP 2 276 883 B2, infectious disease diagnostics, intellectual property, latent tuberculosis, Molecular Diagnostics, patent lawsuit, public health, QIAGEN, QuantiFERON technology, QuantiFERON-TB Gold Plus, SD Biosensor, TB detection, Thierry Bernard, tuberculosis, tuberculosis control, Unified Patent Court, WHO
HILDEN, Deutschland, GERMANTOWN, Maryland (USA), und SHANGHAI, China, 7-Feb-2022 — /EuropaWire/ — QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA), ein deutscher Anbieter von Sample-to-Insights-Lösungen, die es Kunden ermöglichen, Einblicke in die Bausteine des Lebens – DNA, RNA und Proteine … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged China National Medical Products Administration, Chinese Academy of Medical Sciences, Dr. Gao Lei, IGR, Interferon-Gamma Release Assays, Jean-Pascal Viola, NMPA, QFT-Plus, QIAGEN, QIAGEN NV, QIAreach QFT, QIAreach QuantiFERON-TB, QuantiFERON Tuberkulose, QuantiFERON-TB Gold Plus, TB-Bakterien, TB-Diagnose, TB-Infektionen, TB-Tests, TST, Tuberkulin-Hauttest, UNITAID, Weltgesundheitsorganisation, WHO
(PRESS RELEASE) HILDEN, Germany / GERMANTOWN, MD, United Staes / SHANGHAI, 7-Feb-2022 — /EuropaWire/ — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a German provider of Sample to Insights solutions that enable customers to unlock insights from the building … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged China National Medical Products Administration, Chinese Academy of Medical Sciences, Dr. Gao Lei, IGR, Interferon-Gamma Release Assays, Jean-Pascal Viola, NMPA, QFT-Plus, QIAGEN, QIAGEN N.V., QIAreach QFT, QIAreach QuantiFERON-TB, QuantiFERON tuberculosis, QuantiFERON-TB Gold Plus, TB bacteria, TB diagnosis, TB infections, TB testing, TST, Tuberculin Skin Test, UNITAID, WHO, World Health Organization
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?